Friday, February 14, 2014. The results of a meta-analysis published on February 5, 2014 in the journal PLoS One contribute further evidence to an anti-inflammatory benefit for supplementation with marine-derived omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). Researchers in Hangzhou, China selected 68 randomized, controlled trials that examined the effects of omega-3 fatty acids in a total of 4601 participants. Two of the trials involved subjects with chronic autoimmune disease, 48 studies involved those with chronic non-autoimmune diseases (being at risk of or diagnosed with cardiovascular disease), one trial involved patients with autoimmune disease as well as those with non-autoimmune chronic diseases, and 17 involved healthy men and women. Forty-four of the studies involving chronic non-autoimmune disease patients used omega-3 fatty acid supplements and the remainder involved dietary intake of fish. All of the studies involving autoimmune disease patients or healthy participants utilized omega-3 supplements.
Posted on: Sat, 22 Feb 2014 17:48:10 +0000
Trending Topics
Recently Viewed Topics
© 2015